Literature DB >> 2941145

Autologous responses to human leukaemic cells in mixed leucocyte culture.

L K Ashman, D E O'Keefe, C A Juttner, I R Toogood, M S Rice.   

Abstract

Cryopreserved leukaemic blasts and remission non-T cells from 22 patients with acute leukaemia (15 lymphocytic, 7 non-lymphocytic) were tested as stimulators of autologous remission T cells and normal allogeneic T cells in primary and secondary MLC. In most cases the autologous response elicited by leukaemic cells was less than or equal to that elicited by remission non-T cells. However, T cells from 2 patients in long-standing first remission from ANLL displayed greater proliferation in response to leukaemic blasts than to remission non-T cells in both primary and secondary MLC. The results are suggestive of sensitization of these 2 patients to leukaemia-specific antigens, but other possible explanations are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 2941145     DOI: 10.1007/bf00199121

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

Review 1.  The autologous mixed-lymphocyte reaction.

Authors:  M E Weksler; C E Moody; R W Kozak
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

2.  Stimulatory ability of human leukaemic cells in the allogeneic mixed leucocyte reaction.

Authors:  L K Ashman
Journal:  Aust J Exp Biol Med Sci       Date:  1983-08

3.  Antigens associated with acute leukemia detected in the primed lymphocyte test.

Authors:  N L Reinsmoen; J H Kersey; E J Yunis
Journal:  J Natl Cancer Inst       Date:  1978-03       Impact factor: 13.506

4.  Cloning of human lymphocytes reactive with autologous leukemia cells.

Authors:  G Csako; R A Binder; A N Kales; J R Neefe
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

5.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

6.  Peanut agglutinin: a marker for normal and leukaemic cells of the monocyte lineage.

Authors:  D O'Keefe; L Ashman
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

7.  The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

Authors:  E A Grimm; B M Vose; E W Chu; D J Wilson; M T Lotze; A A Rayner; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.

Authors:  S K Lee; R T Oliver
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

9.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.

Authors:  A G Khare; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

View more
  3 in total

1.  Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.

Authors:  G Pawelec; M Reutter; M Owsianowsky; A Rehbein; F W Busch
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

Authors:  L K Ashman; G W Kriek; S J Cooper; D E O'Keefe
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside.

Authors:  G Pawelec; H Schmidt; A Rehbein; F Busch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.